These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 36497084)

  • 21. Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells.
    Collins HM; Abdelghany MK; Messmer M; Yue B; Deeves SE; Kindle KB; Mantelingu K; Aslam A; Winkler GS; Kundu TK; Heery DM
    BMC Cancer; 2013 Jan; 13():37. PubMed ID: 23356739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ARF/oncogene pathway activates p53 acetylation within the DNA binding domain.
    Mellert H; Sykes SM; Murphy ME; McMahon SB
    Cell Cycle; 2007 Jun; 6(11):1304-6. PubMed ID: 17534149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets.
    Narayanan BA; Narayanan NK; Re GG; Nixon DW
    Int J Cancer; 2003 Mar; 104(2):204-12. PubMed ID: 12569576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redox modulation of p53: mechanisms and functional significance.
    Kim DH; Kundu JK; Surh YJ
    Mol Carcinog; 2011 Apr; 50(4):222-34. PubMed ID: 21465572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein Acetylation in Bacteria.
    VanDrisse CM; Escalante-Semerena JC
    Annu Rev Microbiol; 2019 Sep; 73():111-132. PubMed ID: 31091420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-translational modifications of p53 tumor suppressor: determinants of its functional targets.
    Taira N; Yoshida K
    Histol Histopathol; 2012 Apr; 27(4):437-43. PubMed ID: 22374721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site-specific acetylation of p53 directs selective transcription complex assembly.
    Roy S; Tenniswood M
    J Biol Chem; 2007 Feb; 282(7):4765-4771. PubMed ID: 17121856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305.
    Wang YH; Tsay YG; Tan BC; Lo WY; Lee SC
    J Biol Chem; 2003 Jul; 278(28):25568-76. PubMed ID: 12724314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surf the post-translational modification network of p53 regulation.
    Gu B; Zhu WG
    Int J Biol Sci; 2012; 8(5):672-84. PubMed ID: 22606048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulating histone acetyltransferases and deacetylases.
    Legube G; Trouche D
    EMBO Rep; 2003 Oct; 4(10):944-7. PubMed ID: 14528264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signaling to p53: breaking the posttranslational modification code.
    Appella E; Anderson CW
    Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.
    Harrod R; Nacsa J; Van Lint C; Hansen J; Karpova T; McNally J; Franchini G
    J Biol Chem; 2003 Apr; 278(14):12310-8. PubMed ID: 12501250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification.
    Knights CD; Liu Y; Appella E; Kulesz-Martin M
    J Biol Chem; 2003 Dec; 278(52):52890-900. PubMed ID: 14555661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TR-FRET biochemical assays for detecting posttranslational modifications of p53.
    Dudek JM; Horton RA
    J Biomol Screen; 2010 Jun; 15(5):569-75. PubMed ID: 20400726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Posttranslational modifications involved in the DNA damage response.
    Anderson CW; Appella E; Sakaguchi K
    J Protein Chem; 1998 Aug; 17(6):527. PubMed ID: 9723732
    [No Abstract]   [Full Text] [Related]  

  • 36. The Role of Post-Translational Acetylation and Deacetylation of Signaling Proteins and Transcription Factors after Cerebral Ischemia: Facts and Hypotheses.
    Demyanenko S; Sharifulina S
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress.
    Brandl A; Wagner T; Uhlig KM; Knauer SK; Stauber RH; Melchior F; Schneider G; Heinzel T; Krämer OH
    J Mol Cell Biol; 2012 Oct; 4(5):284-93. PubMed ID: 22493095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylation of the DNA binding domain regulates transcription-independent apoptosis by p53.
    Sykes SM; Stanek TJ; Frank A; Murphy ME; McMahon SB
    J Biol Chem; 2009 Jul; 284(30):20197-205. PubMed ID: 19494119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
    Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
    Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Post-translationally Modified p53 by Western Blotting.
    Barber AE; Meek DW
    Methods Mol Biol; 2021; 2267():7-18. PubMed ID: 33786782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.